Momentum Data Ltd
London, WC1X 8QT, United Kingdom
NCT Number: NCT05206734
This study is a large population-based analysis in the United Kingdom (UK) using routine primary care data to investigate the impacts on quality-of-life outcomes and use of healthcare services in people aged 5 - 25 years diagnosed with Inflammatory Bowel Disease (IBD) and the impacts of mental health conditions in those diagnosed with IBD.
Looking for future studies?
Notify Me5 year–25 year
All sexes
Observational
London, WC1X 8QT, United Kingdom
This study will use routinely electronic medical record (EMR) data from primary care practices within the Optimum Patient Care Research Database (OPCRD).
Stream 1 primary objective is to compare the prevalence and cumulative incidence of mental health conditions in children, adolescents and young adults (aged 5-25 years) with a diagnosis of Inflammatory Bowel Disease (IBD), compared to matched population controls without a diagnosis of IBD. The secondary objective is to determine the severity of mental health outcomes in those with and without a diagnosis of IBD.
Stream 2 primary objective is to determine the impact of mental health conditions in children, adolescents and young adults (aged 5-25 years) diagnosed with IBD on quality-of-life indicators, such as records for absence from work or school, unemployment, sleep disturbance and substance abuse.
The secondary objectives are to compare indicators of IBD severity, such as medication use, surgical intervention, nutritional supplement prescriptions and markers of nutritional status including underweight or growth retardation,and healthcare resource utilisation.These impacts and indicators will be assessed using participants that have been diagnosed with IBD, comparing those with the presence of a mental health condition to those without a mental health condition.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Observational analysis of usual care only.
Time frame: 5 years
Cumulative incidence (percentage of participants in each arm who developed any mental health condition) was calculated using Kaplan-Meier analysis
Time frame: Retrospective data assessed from 2010-2020, up to 10 years
Calculated using Cox proportional hazards models using matched controls as the reference group. Adjusted for age, sex, socioeconomic status, ethnicity, and other common chronic childhood conditions.
Time frame: 5 years of follow-up.
Bowel symptoms consist of abdominal pain, bloating, discomfort and diarrhoea. Relative risk in participants with mental health conditions compared with those without mental health (MH) conditions. Calculated using negative binomial regression.
Time frame: 5 years of follow-up.
Relative risk in participants with mental health conditions compared with those without MH conditions. Calculated using Cox regression.
Time frame: 5 years of follow-up.
Relative risk in participants with mental health conditions compared with those without MH conditions. Calculated using negative binomial regression.
Time frame: Retrospective data assessed from 2010-2020, up to 10 years
Probability of developing a mental health condition by age 25 years.Estimated using modified Cox regression models
Time frame: 5 years of follow-up.
Relative risk of increased primary care visits in participants with mental health conditions compared with those without MH conditions. Calculated using negative binomial regression.
Time frame: 5 years of follow-up.
Relative risk of increased hospital admissions in participants with mental health conditions compared with those without MH conditions. Calculated using negative binomial regression.
Momentum Data
Industry
Incidence of Psychological Comorbidities in Paediatric and Young Adults With Inflammatory Bowel Disease, and the Impacts on Quality-of-life, Disease Severity and Resource Utilisation: A Population-based Cohort Study in the United Kingdom
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03847753
Acquired Immunodeficiency Syndrome, Allergy
View Trial DetailsNCT07397195
Anxiety Disorder, Anxiety Disorders
Houston, Texas, United States
View Trial DetailsNCT06575660
Anxiety, Anxiety Disorders
Chicago, Illinois, United States
View Trial DetailsNCT04861597
Anxiety Disorders, Behavior
The Bronx, New York, United States
View Trial Details